Granger Genetics is offering this service to individuals that want to get antibody testing done and it does not require a doctor’s note!
Testing will be available for $139 per person and is available to anyone who wants it. At the testing locations, a licensed phlebotomist will be available to draw your blood sample to be run in our lab. Results should be available within 48 business hours of the sample being collected.
How it works:
- Visit our website and register here.
- After registration, you will be automatically redirected to a page where you can pay. If you have registered and still need to pay you can also click here.
- You will then go to the testing location at 601 Biotech Dr. Suite 301 N. Chesterfield, VA 23235 on the day and time that you registered for. Follow the cones to the designated area and remain in your vehicle with the window rolled up. Our registration person will come to your car window and check you in. Please have a photo ID with you to prove your identity.
- You will then be instructed to pull up to the tent where a licensed phlebotomist will come to your car and draw your sample.
- You should receive your results from within 48 business hours via the method chosen during registration.
Test was FDA Allowed on May 2, 2020. (EUA application #201535 currently under review)
(NOTE: There is a difference between Allowance and Approval. Test kit manufacturers must apply for FDA Approval. Granger Genetics is not a test kit manufacturer. Laboratories like Granger Genetics who are CLIA-accredited to perform complex testing do not apply for FDA approval of their tests. However, labs may voluntarily submit formal “Notice” to the FDA containing all their test validation data, and after the FDA accepts the Notice, the test is referred to as “Allowed”. Granger Genetics’ COVID-19 Antibody Tests are FDA Allowed.)
In most patients, IgG antibodies develop 7-10 days after symptoms of COVID-19 begin. The results of this test may indicate that a person has had COVID-19 in the recent past and has developed antibodies that may offer protection from future infection.
IgM is the first antibody produced by the immune system. A positive IgM test indicates that a person has been infected and has begun to mount/have an immune response to the virus. IgM antibodies disappear soon after the virus has been cleared from the body. A person with a positive IgM test may still have an active infection and should self-isolate.
The gold standard test for detection of neutralizing antibodies uses live virus and cells, making it dangerous, expensive, slow, and not practical for routine diagnostic use. The cPASS™ test is a “surrogate” laboratory test, meaning that it does not require live virus; cPASS™ is just as accurate as the live virus tests at detecting neutralizing antibodies, but it is rapid and inexpensive.
Granger Genetics collaborated closely with the test manufacturer (GenScript, Piscataway, NJ) during the clinical validation of the cPASS™. The cPASS™ diagnostic test has already received its CE-IVD approval in Europe and HSA approval in Singapore. FDA approval is expected within weeks (EUA application #200661). Learn more about the cPASS™ Neutralizing Antibody test by clicking on the links below.
No, we offer this test to anyone that wants it and there is no doctor’s order required.
You will receive your result via the method you selected during registration. Methods available are mail, fax, or encrypted email.
No, we do not bill insurance. You may submit your receipt and results to your insurance company to see if they will reimburse you but we cannot say if they will or will not.
Our COVID-19 antibodies test costs $139.00 and gives you IgM & IgG results.
Our COVID-19 Neutralizing Antibodies test costs $139.00 and tells you if you are positive or negative for neutralizing antibodies.
Our COVID-19 Neutralizing Panel test costs $239.00 and gives you all three! IgM, IgG and Neutralizing antibody results.
Our COVID-19 assays are laboratory developed tests (LDT) to determine the presence of IgM, IgG and Neutralizing antibodies in patients who have been exposed to COVID-19. These assays have been validated and are performed in a CLIA certified high complexity laboratory.